Submitted by Anonymous (not verified) on 20 November 2023 - 10:08
Human medicines European public assessment report (EPAR): Kauliv, teriparatide, Osteoporosis;Osteoporosis, Postmenopausal, Date of authorisation: 12/01/2023, Revision: 1, Status: Authorised
Source: